IN189317B - - Google Patents

Info

Publication number
IN189317B
IN189317B IN1604DE1998A IN189317B IN 189317 B IN189317 B IN 189317B IN 1604DE1998 A IN1604DE1998 A IN 1604DE1998A IN 189317 B IN189317 B IN 189317B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
David Lewis
David Ganderton
Brian Meakin
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN189317(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IN189317B publication Critical patent/IN189317B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1604DE1998 1997-06-13 1998-06-18 IN189317B (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
IN189317B true IN189317B (en, 2012) 2003-02-08

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1604DE1998 IN189317B (en, 2012) 1997-06-13 1998-06-18

Country Status (44)

Country Link
EP (2) EP0920302B2 (en, 2012)
JP (1) JP4380802B2 (en, 2012)
KR (1) KR100546239B1 (en, 2012)
CN (1) CN1138532C (en, 2012)
AR (1) AR012977A1 (en, 2012)
AT (1) ATE222751T1 (en, 2012)
AU (1) AU729966B2 (en, 2012)
BG (1) BG63906B1 (en, 2012)
BR (1) BR9805993B1 (en, 2012)
CA (1) CA2263445C (en, 2012)
CO (1) CO4940408A1 (en, 2012)
CZ (1) CZ295521B6 (en, 2012)
DE (1) DE69807420T3 (en, 2012)
DK (1) DK0920302T4 (en, 2012)
DZ (1) DZ2516A1 (en, 2012)
EA (1) EA001259B1 (en, 2012)
EE (1) EE03664B1 (en, 2012)
ES (1) ES2182351T5 (en, 2012)
GB (1) GB2326334A (en, 2012)
GE (1) GEP20012462B (en, 2012)
HR (1) HRP980317B1 (en, 2012)
HU (1) HU228487B1 (en, 2012)
ID (1) ID21491A (en, 2012)
IL (1) IL128484A (en, 2012)
IN (1) IN189317B (en, 2012)
IS (1) IS2435B (en, 2012)
IT (1) IT1293803B1 (en, 2012)
MA (1) MA26507A1 (en, 2012)
ME (2) MEP44008A (en, 2012)
MY (1) MY119074A (en, 2012)
NO (1) NO327775B1 (en, 2012)
NZ (1) NZ334149A (en, 2012)
PL (1) PL193721B1 (en, 2012)
PT (1) PT920302E (en, 2012)
RS (1) RS51274B (en, 2012)
SA (1) SA98190821B1 (en, 2012)
SI (1) SI0920302T2 (en, 2012)
SK (1) SK284430B6 (en, 2012)
TN (1) TNSN98087A1 (en, 2012)
TR (1) TR199900288T1 (en, 2012)
TW (1) TW555570B (en, 2012)
UA (1) UA70289C2 (en, 2012)
WO (1) WO1998056349A1 (en, 2012)
ZA (1) ZA985136B (en, 2012)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
DE60031504T2 (de) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
AU1534501A (en) * 1999-11-23 2001-06-04 Glaxo Group Limited Pharmaceutical formulations of salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
GEP20063986B (en) 2002-03-01 2006-12-11 Chiesi Farma Spa Formoterol superfine formulation
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
ATE390125T1 (de) * 2003-03-20 2008-04-15 Boehringer Ingelheim Pharma Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
KR101297061B1 (ko) 2004-07-02 2013-08-19 베링거 인겔하임 인터내셔날 게엠베하 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
JP2011503058A (ja) * 2007-11-07 2011-01-27 アストラゼネカ・アクチエボラーグ アスコルビン酸誘導体含有乾燥粉末製剤
EP2613829B1 (en) * 2010-09-06 2022-06-29 Chiesi Farmaceutici S.p.A. Metered-dose inhaler
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
JP6781832B2 (ja) * 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84439B (pt) † 1986-03-10 1989-10-04 Burghart Kurt Processo de preparacao de composicoes farmaceuticas a base de nifedipina
WO1987005210A1 (en) † 1986-03-10 1987-09-11 Kurt Burghart Pharmaceutical preparation and process for preparing the same
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
ES2064160T3 (es) † 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
FI935464A7 (fi) † 1991-06-10 1993-12-07 Schering Corp Kloorifluorihiilettömät aerosoliformulaatiot
ATE226067T1 (de) † 1991-06-10 2002-11-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
CA2125665C (en) * 1991-12-12 2001-06-12 Rachel Ann Akehurst Medicaments
CA2126244C (en) * 1991-12-18 2000-09-26 Robert K. Schultz Suspension aerosol formulations
JP3009924B2 (ja) * 1992-12-09 2000-02-14 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 安定化医用エアーゾル溶液製剤
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
WO1995031182A1 (en) † 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
JP2001505171A (ja) † 1996-12-04 2001-04-17 バイオグラン アイルランド（アール アンド ディ）リミテッド 製薬組成物及びその投与のための装置
PT1014943E (pt) † 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois

Also Published As

Publication number Publication date
EP0920302A1 (en) 1999-06-09
KR20000068171A (ko) 2000-11-25
CO4940408A1 (es) 2000-07-24
HRP980317A2 (en) 1999-04-30
GB9712434D0 (en) 1997-08-13
CA2263445C (en) 2008-09-09
ES2182351T5 (es) 2007-03-16
GB2326334A (en) 1998-12-23
DE69807420T2 (de) 2003-05-08
CZ295521B6 (cs) 2005-08-17
TW555570B (en) 2003-10-01
HK1022271A1 (en) 2000-08-04
TNSN98087A1 (fr) 2005-03-15
EA001259B1 (ru) 2000-12-25
IS2435B (is) 2008-10-15
MA26507A1 (fr) 2004-12-20
CZ46299A3 (cs) 1999-07-14
HUP0001339A3 (en) 2000-10-30
ITMI971798A1 (it) 1999-01-28
SI0920302T1 (en) 2002-12-31
TR199900288T1 (xx) 1999-09-21
ZA985136B (en) 1999-01-07
MY119074A (en) 2005-03-31
SK284430B6 (sk) 2005-04-01
EE9900055A (et) 1999-08-16
PL331531A1 (en) 1999-07-19
EE03664B1 (et) 2002-04-15
SK17699A3 (en) 1999-07-12
ME00333B (me) 2011-02-10
JP2000516965A (ja) 2000-12-19
HUP0001339A2 (hu) 2000-09-28
GEP20012462B (en) 2001-06-25
UA70289C2 (uk) 2004-10-15
CA2263445A1 (en) 1998-12-17
SI0920302T2 (sl) 2006-10-31
YU6999A (sh) 2000-03-21
AU729966B2 (en) 2001-02-15
HU228487B1 (en) 2013-03-28
IT1293803B1 (it) 1999-03-10
AR012977A1 (es) 2000-11-22
IS4974A (is) 1999-02-11
BR9805993B1 (pt) 2009-05-05
AU8626298A (en) 1998-12-30
EP0920302B2 (en) 2006-06-21
BG63906B1 (bg) 2003-06-30
ATE222751T1 (de) 2002-09-15
DK0920302T4 (da) 2006-10-09
BG103221A (en) 1999-09-30
MEP44008A (en) 2011-02-10
CN1138532C (zh) 2004-02-18
SA98190821B1 (ar) 2006-11-19
NO990594D0 (no) 1999-02-09
ID21491A (id) 1999-06-17
IL128484A (en) 2004-09-27
NZ334149A (en) 2000-07-28
DE69807420T3 (de) 2006-11-16
EP1219293A3 (en) 2003-05-28
EA199900201A1 (ru) 1999-06-24
WO1998056349A1 (en) 1998-12-17
NO990594L (no) 1999-04-13
IL128484A0 (en) 2000-01-31
DK0920302T3 (da) 2002-12-23
ES2182351T3 (es) 2003-03-01
PT920302E (pt) 2002-11-29
DZ2516A1 (fr) 2004-11-08
HRP980317B1 (en) 2002-06-30
EP1219293A2 (en) 2002-07-03
JP4380802B2 (ja) 2009-12-09
PL193721B1 (pl) 2007-03-30
DE69807420D1 (de) 2002-10-02
CN1229355A (zh) 1999-09-22
EP0920302B1 (en) 2002-08-28
BR9805993A (pt) 1999-08-31
NO327775B1 (no) 2009-09-21
RS51274B (sr) 2010-12-31
KR100546239B1 (ko) 2006-01-26

Similar Documents

Publication Publication Date Title
DE69840720D1 (en, 2012)
IN190318B (en, 2012)
ITTO970381A0 (en, 2012)
IN189317B (en, 2012)
CH0944937H2 (en, 2012)
ITPD970083A0 (en, 2012)
IN183180B (en, 2012)
IN186539B (en, 2012)
BE2013C047I2 (en, 2012)
ITMI971501A0 (en, 2012)
ITRM970299A0 (en, 2012)
ITRM970354A0 (en, 2012)
IN184141B (en, 2012)
ITTV970032A0 (en, 2012)
IN186874B (en, 2012)
ITMI971399A0 (en, 2012)
CN3058533S (en, 2012)
CN3058162S (en, 2012)
CN3055389S (en, 2012)
CN3054099S (en, 2012)
CN3055179S (en, 2012)
CN3055123S (en, 2012)
CN3058923S (en, 2012)
CN3054902S (en, 2012)
CN3055471S (en, 2012)